Serious Infections Among Adult Medicaid Beneficiaries With Systemic Lupus Erythematosus and Lupus Nephritis

To examine the epidemiology of serious infections, a significant cause of morbidity and mortality in systemic lupus erythematosus (SLE), in a nationwide cohort of SLE and lupus nephritis (LN) patients.

[1]  G. Alarcón,et al.  Racial/Ethnic Variation in All‐Cause Mortality Among United States Medicaid Recipients With Systemic Lupus Erythematosus: A Hispanic and Asian Paradox , 2015, Arthritis & rheumatology.

[2]  W. Winkelmayer,et al.  Physician visits and 30-day hospital readmissions in patients receiving hemodialysis. , 2014, Journal of the American Society of Nephrology : JASN.

[3]  Jun Liu,et al.  Epidemiology and sociodemographics of systemic lupus erythematosus and lupus nephritis among US adults with Medicaid coverage, 2000-2004. , 2013, Arthritis and rheumatism.

[4]  F. Wolfe,et al.  Increased incidence of herpes zoster among patients with systemic lupus erythematosus , 2013, Lupus.

[5]  G. Alarcón,et al.  Prevalence, incidence, and demographics of systemic lupus erythematosus and lupus nephritis from 2000 to 2004 among children in the US Medicaid beneficiary population. , 2012, Arthritis and rheumatism.

[6]  M. Lam,et al.  Survival analysis and causes of mortality in patients with lupus nephritis. , 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[7]  L. Magder,et al.  Differences between Male and Female Systemic Lupus Erythematosus in a Multiethnic Population , 2012, The Journal of Rheumatology.

[8]  Kuang-Hui Yu,et al.  Cytomegalovirus infection causes morbidity and mortality in patients with autoimmune diseases, particularly systemic lupus: in a Chinese population in Taiwan , 2012, Rheumatology International.

[9]  M Alan Brookhart,et al.  Trends in the incidence, demographics, and outcomes of end-stage renal disease due to lupus nephritis in the US from 1995 to 2006. , 2011, Arthritis and rheumatism.

[10]  L. Chibnik,et al.  Identification and validation of lupus nephritis cases using administrative data , 2010, Lupus.

[11]  M. Ramos-Casals.  Viruses and lupus: the viral hypothesis , 2008, Lupus.

[12]  M. Ward.  Medical insurance, socioeconomic status, and age of onset of endstage renal disease in patients with lupus nephritis. , 2007, The Journal of rheumatology.

[13]  Sebastian Schneeweiss,et al.  Anti-tumor necrosis factor α therapy and the risk of serious bacterial infections in elderly patients with rheumatoid arthritis , 2007 .

[14]  Y. Lau,et al.  Mannose-binding lectin and susceptibility to infection in Chinese patients with systemic lupus erythematosus. , 2007, The Journal of rheumatology.

[15]  S. Schneeweiss,et al.  Veteran's affairs hospital discharge databases coded serious bacterial infections accurately. , 2007, Journal of clinical epidemiology.

[16]  H. Leu,et al.  Invasive fungal infection in systemic lupus erythematosus: an analysis of 15 cases and a literature review. , 2007, Rheumatology.

[17]  Deficiency of functional mannose-binding lectin is not associated with infections in patients with systemic lupus erythematosus , 2006, Arthritis research & therapy.

[18]  R. Cervera,et al.  Infections in systemic lupus erythematosus: a prospective and controlled study of 110 patients , 2006, Lupus.

[19]  Y. Shoenfeld,et al.  Infections and SLE , 2005, Autoimmunity.

[20]  A. Malaviya,et al.  Infection-related morbidity in systemic lupus erythematosus: A clinico-epidemiological study from Northern India , 2005, Rheumatology International.

[21]  A. Cassone,et al.  Effects of chloroquine on viral infections: an old drug against today's diseases , 2003, The Lancet Infectious Diseases.

[22]  G. Hughes,et al.  Morbidity and Mortality in Systemic Lupus Erythematosus During a 10-Year Period: A Comparison of Early and Late Manifestations in a Cohort of 1,000 Patients , 2003, Medicine.

[23]  D. Gladman,et al.  The nature and outcome of infection in systemic lupus erythematosus , 2002, Lupus.

[24]  A. Voss,et al.  Association of mannose-binding lectin gene variation with disease severity and infections in a population-based cohort of systemic lupus erythematosus patients , 2001, Genes and Immunity.

[25]  L. Mouthon,et al.  Risk factors and prognostic influence of infection in a single cohort of 87 adults with systemic lupus erythematosus , 2001, Annals of the rheumatic diseases.

[26]  L. Ramos,et al.  Case Report. Cutaneous cryptococcosis in a patient with systemic erythematous lupus , 2001, Mycoses.

[27]  A. Fraga,et al.  Infections in outpatients with systemic lupus erythematosus: a prospective study , 2001, Lupus.

[28]  E. Bouza,et al.  Infections in systemic lupus erythematosus and rheumatoid arthritis. , 2001, Infectious disease clinics of North America.

[29]  J. Reveille,et al.  Systemic lupus erythematosus in three ethnic groups. VIII. Predictors of early mortality in the LUMINA cohort , 2001 .

[30]  J. Reveille,et al.  Systemic lupus erythematosus in three ethnic groups. VII [correction of VIII]. Predictors of early mortality in the LUMINA cohort. LUMINA Study Group. , 2001, Arthritis and rheumatism.

[31]  M. Ward.  Development and testing of a systemic lupus-specific risk adjustment index for in-hospital mortality. , 2000, The Journal of rheumatology.

[32]  D. Raoult,et al.  Treatment of Q fever endocarditis: comparison of 2 regimens containing doxycycline and ofloxacin or hydroxychloroquine. , 1999, Archives of internal medicine.

[33]  D. Gladman,et al.  Mortality studies in systemic lupus erythematosus. Results from a single center. III. Improved survival over 24 years. , 1997, The Journal of rheumatology.

[34]  Michal Abrahamowicz,et al.  Time-Dependent Hazard Ratio: Modeling and Hypothesis Testing with Application in Lupus Nephritis , 1996 .

[35]  L. Kahl,et al.  Risk factors for serious infection during treatment with cyclophosphamide and high-dose corticosteroids for systemic lupus erythematosus. , 1996, Arthritis and rheumatism.

[36]  T. Akama,et al.  Predicting infection in hospitalized patients with systemic lupus erythematosus. , 1996, Internal medicine.

[37]  S. Studenski,et al.  Causes of death in systemic lupus erythematosus. Long-term followup of an inception cohort. , 1995, Arthritis and rheumatism.

[38]  D. Gladman,et al.  Mortality studies in systemic lupus erythematosus. Results from a single center. I. Causes of death. , 1995, The Journal of rheumatology.

[39]  The viral hypothesis. , 1995, Advances in neurology.

[40]  M. Vatanasuk,et al.  Infection in systemic lupus erythematosus. , 1993, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.

[41]  M. Petri,et al.  Incidence of and risk factors for hospitalizations in systemic lupus erythematosus: a prospective study of the Hopkins Lupus Cohort. , 1992, The Journal of rheumatology.

[42]  Y. Niho,et al.  High incidence of herpes zoster in patients with systemic lupus erythematosus: an immunological analysis. , 1990, Annals of the rheumatic diseases.

[43]  M. Petri,et al.  Fatal Infections in Systemic Lupus Erythematosus: The Role of Opportunistic Organisms , 1987, Medicine.

[44]  D. Gladman,et al.  Mortality in systemic lupus erythematosus: the bimodal pattern revisited. , 1985, The Quarterly journal of medicine.

[45]  E. Ginzler,et al.  Computer analysis of factors influencing frequency of infection in systemic lupus erythematosus. , 1978, Arthritis and rheumatism.

[46]  R. S. Gordon,et al.  Incidence of infection in systemic lupus erythematosus. , 1974, Arthritis and rheumatism.